⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALGS News
Aligos Therapeutics, Inc. Common Stock
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
globenewswire.com
ALGS
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
globenewswire.com
ALGS
JNJ
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ALGS
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
globenewswire.com
ALGS
NAMU Introduces Recovery Slide Featuring Soleic® -- High-Performance and Microplastics-Free Polyurethane
prnewswire.com
ALGS
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ALGS
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
globenewswire.com
ALGS
Aligos Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
ALGS
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
globenewswire.com
ALGS
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
globenewswire.com
ALGS